Company profile
Destiny Pharma PLC
Destiny Pharma | World-leading infection prevention.
World-leading infection prevention.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQ0MjQ5Mjc3NmFkaXF6a2N4
Published 08 Nov 2024 04:03
Liquidation In Administration Result Creditors Meeting
InsolvencyAM07 | Transaction MzQ0MTI2NzIzNmFkaXF6a2N4 | Paper/PDF filed
Published 06 Nov 2024 07:22
Liquidation In Administration Statement Of Affairs With Form Attached
InsolvencyAM02 | Transaction MzQzOTE0MzE1M2FkaXF6a2N4 | Paper/PDF filed
Published 20 Oct 2024 06:13
Liquidation In Administration Proposals
InsolvencyAM03 | Transaction MzQzOTE4NDQ3MWFkaXF6a2N4 | Paper/PDF filed
Published 20 Oct 2024 06:11
Resolution
ResolutionRESOLUTIONS | Transaction QURBTTVTVVphZGlxemtjeA | Paper/PDF filed
Published 05 Sep 2024 06:33
Certificate Re Registration Public Limited Company To Private
Change-of-nameCERT10 | Transaction MzQzNDI5NTYzN2FkaXF6a2N4 | Paper/PDF filed
Published 05 Sep 2024 06:19
Re Registration Memorandum Articles
IncorporationMAR | Transaction MzQzNDI5NTYzNmFkaXF6a2N4 | Paper/PDF filed
Published 05 Sep 2024 06:14
Reregistration Public To Private Company
Change-of-nameRR02 | Transaction MzQzNDI5NTM0MmFkaXF6a2N4 | Paper/PDF filed
Published 05 Sep 2024 06:09
Liquidation In Administration Appointment Of Administrator
InsolvencyAM01 | Transaction MzQzMzEyNDAxMGFkaXF6a2N4 | Paper/PDF filed
Published 03 Sep 2024 07:02
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzQzMzEyNDI0OWFkaXF6a2N4 | Paper/PDF filed
Published 31 Aug 2024 07:00
Accounts filed
AccountsLast accounts made up date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
SPOR-COV: Prophylaxis of COVID-19 using Innate Immunity
1 Sep 2020 to 31 Oct 2022
The COVID-19 pandemic demonstrates the need for a rapid response to a global public health emergency. Vaccination is ideal but, as is now apparent, a vaccine for an unknown disease cannot be produced in time to avert a major socio-economic disaster. Alternative strategies have been considered but so far have received little attention. One of these is that...
Evaluation of the Novel XF Drugs as Bacterial Resistance Breakers
1 Jan 2019 to 31 Aug 2022
There is an urgent need for new drugs to treat infections resulting from bacteria that are now resistant to many of the current marketed antibiotics. This is a global issue encountered in low and middle-income countries (LMICs) where healthcare provisions may be less prevalent and so the impact is even greater. The jointly funded UK Department of Health a...